Amber Khan in Houston, Texas

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2003
The Primary Medical Specialty for Amber Khan is listed as: Rheumatology
Approximate Years of Experience: 21
PAC (PECOS ID)#: 1456534015
NPI #: 1811108475
NPI Created On: 05/25/2007
NPI Last Updated Listed as: 03/15/2016
Primary Taxonomy Code: 207R00000X
License Number:
57011842
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Community Health Choice
• Celtic Insurance Company
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Mri scan of arm
3. Mri scan of arm joint
4. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
7. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
8. Infusion of chemotherapy into a vein up to 1 hour
9. Infusion of chemotherapy into a vein
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient visit, typically 5 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
15. Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
16. Injection, denosumab, 1 mg
17. Injection, methylprednisolone acetate, 80 mg
18. Injection, diphenhydramine hcl, up to 50 mg
19. Injection, golimumab, 1 mg, for intravenous use
20. Injection, infliximab, excludes biosimilar, 10 mg